The week in health tech, explained in plain English.Get the free newsletter →
October 30, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

New ACA Rule Adds Plan Choices and Higher Deductibles

The Trump administration has finalized a long-awaited rule reshaping the kinds of coverage insurers can sell on the Affordable Care Act marketplaces, according to KFF Health News. The rule embraces new plan designs, including some with out-of-pocket costs roughly 30% higher than current limits, and a more novel approach that lets insurers offer coverage without a set network of doctors and hospitals.

In practice, that means shoppers will likely see more options at lower premiums, paired with the trade-off of larger deductibles and copays when they actually use care. The network-free design departs from the standard model of fixed provider networks, potentially giving patients wider access but less certainty about negotiated rates and cost protection.

Supporters frame the changes as a way to expand choice and affordability for people who find current plans too expensive. Critics counter that higher cost-sharing and the absence of defined networks could expose consumers to unexpected bills and weaken the coverage guarantees the ACA was built to provide.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.